The Ohio State spinout has gone public in an upsized IPO sized at approximately $182m.

Entrada Therapeutics, a US-based drug delivery platform developer spun out of Ohio State University, raised almost $182m in late October in an initial public offering.

The offering involved the sale of just over 9 million shares, priced at $20 each on the Nasdaq Global Market. It was upsized from 7.5 million shares which were priced at the middle of its $19 to $21 range.

Entrada has developed endosomal escape vehicle (EEV) technology that precisely delivers medication to both large and…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Fernando Moncada Rivera

Fernando Moncada Rivera is a reporter at Global Corporate Venturing and also host of the CVC Unplugged podcast.
email Linked in